QLT is a biotechnology company focused on the development and commercialization of advanced ocular products that address unmet medical needs for patients and clinicians across the globe. The company is dedicated to developing its synthetic retinoid program for treating certain inherited retinal diseases, as well as developing its proprietary punctal plug delivery system and marketing the commercial product Visudyne in the U.S. For more information, visit the company’s Web site at www.qltinc.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: